Linking medicinal/nutraceutical products research with commercialization

Pharmaceutical Biology

Volumn 43, Issue 5, 2005, Pages 425-433

  Cameron, S I ^a   Smith, R F ^a   Kierstead, K E ^b  

^a LAURENTIAN FORESTRY CENTRE   (Canada)

^b Lyceum Research   (Canada)

Author keywords

Bioproduct market; Commercialization; Medical crop; Paclitaxel; Pharmaceutical crop

Indexed keywords

10 DEACETYLBACCATIN III; 13 ACETYL 9 DIHYDROACCATIN III; ACETYLSALICYLIC ACID; BETULIC ACID; CAMPTOTHECIN; DITERPENOID; DOCETAXEL; ELLAGIC ACID; GLUCOSAMINE; NUTRACEUTICAL; PACLITAXEL; PLANT EXTRACT; PODOPHYLLOTOXIN; PYGEUM AFRICANUM EXTRACT; TAXANE DERIVATIVE; TAXUS CANADENSIS EXTRACT; UNCARIA TOMENTOSA EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; COMMERCIAL PHENOMENA; COMMODIFICATION; CROP PRODUCTION; DRUG COST; DRUG MARKETING; ECHINACEA; EXTRACTION; GOVERNMENT REGULATION; HARVESTING; INDUSTRIAL WORKER; MARKET; MARKETING; MEDICAL RESEARCH; MEDICINAL PLANT; NONHUMAN; PACKAGING; PHYTOCHEMISTRY; PROSTATE DISEASE; RAW FOOD; SPECIES CULTIVATION; TAXUS;

TAXUS CANADENSIS;

EID: 24744450955     PISSN: 13880209     EISSN: None     Source Type: Journal    
DOI: 10.1080/13880200590963736     Document Type: Article

References (29)

1. Anonymous (1999): Evaluation of ellagic acid content of Ohio berries-Final Report, Ohio State University Extension Information. Available at http://fruit.osu. edu/eacid_final.html
2. Anonymous (2002): Update on spindle poisons-Part I. Taxanes, generic paclitaxel, and novel formulations and analogs. Future Oncology 6: 1422-1455.
3. Baloglu E, Kingston DGI (1999): The taxane diterpenoids. J Nat Prod 62: 1448-1472.
4. Croom EM (1995): Taxus for taxol and taxoids. In: Suffness M, ed., Taxol®: Science and Applications. Boca Raton, FL, CRC Press, pp. 37-70.
5. Cunningham AB, Mbenkum FT (1993): Sustainability of harvesting Prunus africana bark in Cameroon: A medicinal plant in international trade. People and Plants Working Paper 2. Paris, UNESCO, p. 28.
6. DasGupta TK, Pezzuto JM (1997): Method and composition for selectively inhibiting melanoma using betulinic acid. US Patent No. 5,658,947.
7. DiMasi JA, Hansen RW, Grabowski HG (2003): The price of innovation: New estimates of drug development costs. J Health Econ 22: 151-185.
8. Farnsworth, NN, Soejarto, DD (1991): Global importance of medicinal plants. In: Akerle O, Heywood OV, Synge H, eds., Conservation of Medicinal Plants. Cambridge, UK, Cambridge University Press, pp. 25-51.
9. Garber K (2002): Battle over generic taxol concludes, but controversy continues. J Natl Cancer Inst 94: 324-326.
10. Goodman, J, Walsh V (2001): The Story of Taxol: Nature and Politics in Pursuit of an Anti-Cancer Drug. Cambridge, UK, Cambridge University Press, pp. 282.
11. Govindachari TR, Viswanathan N (1972): Alkaloids of Mappia foetida. Phytochemistry 11: 3529-3531.
12. Iwu, MM (2002a): Ethnobotanical approach to pharmaceutical drug discovery: Strengths and limitations. In: Iwu MM, Wootton JC, eds., Ethnomedicine and Drug Discovery. New York, Elsevier, pp. 309-320.
13. Iwu, MM (2002b): Introduction: Therapeutic agents from ethnomedicine. In: Iwu MM, Wootton JC, eds., Ethnomedicine and Drug Discovery. New York, Elsevier, pp. 1-22.
14. Iwu, MM, Diop AD, Miserole L, Okuni CO (2002): Garcinia kola: A new look at an old adaptogenic agent. In: Iwu MM, Wootton JC, eds., Ethnomedicine and Drug Discovery. New York, Elsevier, pp. 191-199.
15. Leakey RRB, Izac A-MN (1996): Linkages between domestication and commercialization of non-timber forest products: Implications for agroforestry. In: Leakey RRB, Temu AB, Melnyk M, Vantomme P, eds., Domestication and Commercialization of Non-timber Forest Products: Implications in Agroforestry Systems. Rome, FAO, pp. 1-7.
16. Leakey RRB, Newton AC (1994): Domestication of 'Cinderella' species as the start of a woody-plant revolution. In: Leakey RRB, Newton AC, eds., Tropical Trees: Potential for Domestication and the Rebuilding of Forest Resources. London, HMSO, pp. 3-5.
17. Manual of Patent Examining Procedure (2001). Chapter 2100, Section 2105, "Patentable Subject Matter-Living Subject Matter," 8th ed. (rev. May 2004). Washington, DC, U.S. Department of Commerce. USPTO. Available at http://www.uspto.gov/web/offices/pac/mpep/mpep.htm
18. Marles RJ, Clavelle C, Monteleone L, Tays N, Burns D (2000): Aboriginal Plant Use in Canada's Northwest Boreal Forest, Vancouver BC, UBC Press, pp. 253-256.
19. McChesney JD (2000): Commercialization of plant-derived natural products as pharmaceuticals: A view from the trenches. In: Cutler SJ, Cutler HG, eds., Biologically Active Natural Products: Pharmaceuticals. Boca Raton, FL, CRC Press, pp. 253-264.
20. Moerman DE (1998): Native American Ethnobotany. Portland, OR, Timber Press, pp. 11-28.
21. Moraes RM, Burandt C Jr., Ganzera M, Li X, Khan I, Canel C (2000): The American mayapple revisited-Podophyllum peltatum-still a potential cash crop? Econ Bot 54: 471-476.
22. Nikolakakis A, Caron G, Cherestes A, Sauriol F, Mamer O, Zamir LO (2000). Taxus canadensis abundant taxane: Conversion to paclitaxel and rearrangements. Bioorganic Med Chem 8: 1269-1280.
23. Shaw A (1987): Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances. Section II.D.6.C (1). Washington, DC, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration. Available at http://www.fda.gov/cder/guidance/drugsub.pdf
24. Schippmann U (2001): Medicinal Plants Significant Trade Study. CITES Document PC9.9.1.3 (rev.). Bonn, Bundesamt für Naturschutz (BIN), pp. 71-74.
25. Schmidt RJ (2002): The Botanical Dermatology Database (BoDD): Cupressaceae (Cypress family). Available at http://bodd.cf.ac.uk/BotDermFolder/ BotDermC/CUPR.html
26. Small E, Catling PM (1999): Canadian Medicinal Crops. Ottawa, NRC Research Press, pp. 240.
27. Walker K, Croteau R (2001). Taxol biosynthetic genes. Phytochemistry 58: 1-7.
28. Wall ME, Wani MC, Nicholas AW, Manikumar G (1990): Synthesis of camptothecin and analogs thereof. U.S. Patent No. 4,894,456.
29. Williams JE (2001): Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Uña de Gato and Sangre de Grado. Altern Med Rev 6: 567-579.